168 related articles for article (PubMed ID: 32294981)
1. Expression Profile and Prognostic Significance of EPHB3 in Colorectal Cancer.
Jang BG; Kim HS; Bae JM; Kim WH; Hyun CL; Kang GH
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32294981
[TBL] [Abstract][Full Text] [Related]
2. Receptor Tyrosine Kinase EphB3: a Prognostic Indicator in Colorectal Carcinoma.
Xuan Z; Huang J; Gao L; Wang Y; Wang J; Sun Y
Pathol Oncol Res; 2020 Jan; 26(1):541-549. PubMed ID: 30535864
[TBL] [Abstract][Full Text] [Related]
3. SMOC2, an intestinal stem cell marker, is an independent prognostic marker associated with better survival in colorectal cancers.
Jang BG; Kim HS; Bae JM; Kim WH; Kim HU; Kang GH
Sci Rep; 2020 Sep; 10(1):14591. PubMed ID: 32884102
[TBL] [Abstract][Full Text] [Related]
4. Silencing of the EPHB3 tumor-suppressor gene in human colorectal cancer through decommissioning of a transcriptional enhancer.
Jägle S; Rönsch K; Timme S; Andrlová H; Bertrand M; Jäger M; Proske A; Schrempp M; Yousaf A; Michoel T; Zeiser R; Werner M; Lassmann S; Hecht A
Proc Natl Acad Sci U S A; 2014 Apr; 111(13):4886-91. PubMed ID: 24707046
[TBL] [Abstract][Full Text] [Related]
5. EphB3-targeted regulation of miR-149 in the migration and invasion of human colonic carcinoma HCT116 and SW620 cells.
Zhang G; Liu X; Li Y; Wang Y; Liang H; Li K; Li L; Chen C; Sun W; Ren S; Zhu P; Zhang L
Cancer Sci; 2017 Mar; 108(3):408-418. PubMed ID: 28370854
[TBL] [Abstract][Full Text] [Related]
6. Expression Profile of LGR5 and Its Prognostic Significance in Colorectal Cancer Progression.
Jang BG; Kim HS; Chang WY; Bae JM; Kim WH; Kang GH
Am J Pathol; 2018 Oct; 188(10):2236-2250. PubMed ID: 30036518
[TBL] [Abstract][Full Text] [Related]
7. SNAIL1 combines competitive displacement of ASCL2 and epigenetic mechanisms to rapidly silence the EPHB3 tumor suppressor in colorectal cancer.
Rönsch K; Jägle S; Rose K; Seidl M; Baumgartner F; Freihen V; Yousaf A; Metzger E; Lassmann S; Schüle R; Zeiser R; Michoel T; Hecht A
Mol Oncol; 2015 Feb; 9(2):335-54. PubMed ID: 25277775
[TBL] [Abstract][Full Text] [Related]
8. TRIB3 Interacts With β-Catenin and TCF4 to Increase Stem Cell Features of Colorectal Cancer Stem Cells and Tumorigenesis.
Hua F; Shang S; Yang YW; Zhang HZ; Xu TL; Yu JJ; Zhou DD; Cui B; Li K; Lv XX; Zhang XW; Liu SS; Yu JM; Wang F; Zhang C; Huang B; Hu ZW
Gastroenterology; 2019 Feb; 156(3):708-721.e15. PubMed ID: 30365932
[TBL] [Abstract][Full Text] [Related]
9. Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours.
Guo DL; Zhang J; Yuen ST; Tsui WY; Chan AS; Ho C; Ji J; Leung SY; Chen X
Carcinogenesis; 2006 Mar; 27(3):454-64. PubMed ID: 16272170
[TBL] [Abstract][Full Text] [Related]
10. Over-expression of EphB3 enhances cell-cell contacts and suppresses tumor growth in HT-29 human colon cancer cells.
Chiu ST; Chang KJ; Ting CH; Shen HC; Li H; Hsieh FJ
Carcinogenesis; 2009 Sep; 30(9):1475-86. PubMed ID: 19483190
[TBL] [Abstract][Full Text] [Related]
11. Solute carrier organic anion transporter family member 4A1 (SLCO4A1) as a prognosis marker of colorectal cancer.
Ban MJ; Ji SH; Lee CK; Bae SB; Kim HJ; Ahn TS; Lee MS; Baek MJ; Jeong D
J Cancer Res Clin Oncol; 2017 Aug; 143(8):1437-1447. PubMed ID: 28378090
[TBL] [Abstract][Full Text] [Related]
12. miRNA-503 Promotes Tumor Progression and Is Associated with Early Recurrence and Poor Prognosis in Human Colorectal Cancer.
Noguchi T; Toiyama Y; Kitajima T; Imaoka H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Toden S; Kusunoki M
Oncology; 2016; 90(4):221-31. PubMed ID: 26999740
[TBL] [Abstract][Full Text] [Related]
13. EZH2-mediated epigenetic suppression of EphB3 inhibits gastric cancer proliferation and metastasis by affecting E-cadherin and vimentin expression.
Zhao K; He J; Wang YF; Jin SD; Fan Y; Fang N; Qian J; Xu TP; Guo RH
Gene; 2019 Feb; 686():118-124. PubMed ID: 30408551
[TBL] [Abstract][Full Text] [Related]
14. The Prognostic Value of Cancer Stem Cell Markers (Notch1, ALDH1, and CD44) in Primary Colorectal Carcinoma.
Mohamed SY; Kaf RM; Ahmed MM; Elwan A; Ashour HR; Ibrahim A
J Gastrointest Cancer; 2019 Dec; 50(4):824-837. PubMed ID: 30136202
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of ARHGAP15 promotes the development of colorectal cancer through PTEN/AKT/FOXO1 axis.
Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
Cell Death Dis; 2018 Jun; 9(6):673. PubMed ID: 29867200
[TBL] [Abstract][Full Text] [Related]
16. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
[TBL] [Abstract][Full Text] [Related]
17. Fusobacterium nucleatum Increases Proliferation of Colorectal Cancer Cells and Tumor Development in Mice by Activating Toll-Like Receptor 4 Signaling to Nuclear Factor-κB, and Up-regulating Expression of MicroRNA-21.
Yang Y; Weng W; Peng J; Hong L; Yang L; Toiyama Y; Gao R; Liu M; Yin M; Pan C; Li H; Guo B; Zhu Q; Wei Q; Moyer MP; Wang P; Cai S; Goel A; Qin H; Ma Y
Gastroenterology; 2017 Mar; 152(4):851-866.e24. PubMed ID: 27876571
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic silencing of diacylglycerol kinase gamma in colorectal cancer.
Kai M; Yamamoto E; Sato A; Yamano HO; Niinuma T; Kitajima H; Harada T; Aoki H; Maruyama R; Toyota M; Hatahira T; Nakase H; Sugai T; Yamashita T; Toyota M; Suzuki H
Mol Carcinog; 2017 Jul; 56(7):1743-1752. PubMed ID: 28218473
[TBL] [Abstract][Full Text] [Related]
19. EphB3 receptor suppressor invasion, migration and proliferation in glioma by inhibiting EGFR-PI3K/AKT signaling pathway.
Xiao Z; Huang S; Qiu W; Pang M; Zeng X; Xu X; Yang Y; Yang B; Chu L
Brain Res; 2024 May; 1830():148796. PubMed ID: 38341169
[TBL] [Abstract][Full Text] [Related]
20. SOX2 expression is associated with a cancer stem cell state and down-regulation of CDX2 in colorectal cancer.
Lundberg IV; Edin S; Eklöf V; Öberg Å; Palmqvist R; Wikberg ML
BMC Cancer; 2016 Jul; 16():471. PubMed ID: 27411517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
